Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.

We are delighted to share the second case review in our series dedicated to the treatment of pediatric CML (pCML) in low and middle-income countries (LMICs) that highlights a challenging case from Brazil. Experts discuss treatment discontinuation in a child with CML who has not achieved a sustained deep molecular response.

Cases of Patients Treated in Countries With Limited Resources and Discussed by Experts of the International CML Foundation (iCMLf)—Case No. 2: Treatment-Free Remission After 9 Years of Imatinib Treatment Without Prior Achievement of Sustained Deep Molecular Response.
Michalowski, MB et al. Case Reports in Oncological Medicine, March 2025 – open access publication

This series of pediatric CML case reviews aims to provide a comprehensive discussion of challenging pCML cases from various perspectives to enhance knowledge and improve patient outcomes.

Other latest publications include:

• How I treat chronic myeloid leukemia in children and adolescents
  Chen J et al. Blood, January 2026
• Predictors of response to imatinib therapy and long-term outcomes in pediatric and adolescent patients with chronic myeloid leukemia
  Saha S et al. Cancer Rep (Hobokken), January 2026 – open access publication
• Safety profiles of dasatinib in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database
  Yang Y et al. Jpn J Clin Oncol, January 2026 – open access publication
• Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG(Plus)-CML 2023
  Fan Z et al. Cancer, December 2025 – open access publication
• Catch-up growth after switch to asciminib in a twin with chronic myeloid leukemia
  Sembill S et al. Lancet, November 2025 (epub ahead of print) – open access publication
• An old leukaemia in young patients – Genetic characteristics of paediatric chronic myeloid leukemia – Review
  Metzler M et al. Br J Haematol, Sept 2025 (epub ahead of print)
• Children with chronic phase chronic myeloid leukemia: Characteristics and outcomes from the International Registry of Childhood CML
  Millot F et al. Haematologica, October 2025 (epub ahead of print) – open access publication
• Pediatric chronic myeloid leukemia: A decade of clinical experience at the NBL specialized hospital for children
  Bourusky M et al. Leuk Res Rep, October 2025 – open access publication
• Safety profiles of dasatinib in pediatric patients: A real-world pharmacovigilance assessment based on the FAERS database
  Yang Y et al. Jp J Clin Oncol, October 2025 (epub ahead of print) 
  – open access publication
• A cross-sectional analysis of the global burden of childhood leukemia from 1990-2021
  Wang P et al. J Cancer Res Clin Oncol, October 2025 – open access publication
• Complications at diagnosis of pediatric chronic myeloid leukemia in chronic phase
  Roy Moulik N et al. Pediatr Blood Cancer, August 2025 (epub ahead of print) 
  – open access publication
• NAMP-mediated deacetylation of HSLS1 protein promotes clonogenic growth of pediatric CML cells
  Samareh B et al. Exp Hematol, August 2025 – open access publication
• Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia
  Krizkova J et al. Leukemia, July 2025 – open access publication
• Long-term endocrine outcomes and quality of life in pediatric and young chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: A prospective study from India
  Mohan R et al. Front Oncol, July 2025 – open access publication
• Rare manifestations of pediatric chronic myeloid leukemia: A case report on priapism and a literature review
  Budair R et al. Front Oncol, June 2025 – open access publication
• Quality of life and adherence to tyrosine kinase inhibitors among pediatric, adolescent, and young adult chronic myeloid leukemia patients: A systematic Review
  Werk RS et al. Pediatr Blood Cancer, June 2025 – open access publication
• Survival of European children, adolescents, and young adults diagnosed with haematological malignancies in the period 2000 – 2013: Results from EUROCARE-6, a population based study
  Trama A et al. Eur J Cancer, June 2025 – open access publication
• Genomic variant profiling in blast-phase paediatric chronic myeloid leukemia: Predisposing and driving alterations
  Behrens YL et al. Br J Haematol, May 2025 (epub ahead of print) – open access publication
• Allogeneic hematopoietic stem cell transplantation in pediatric and young adult patients with chronic myeloid leukemia in tyrosine kinase inhibitor er: A study of the Korean Blood and Marrow Transplantation Registry
  Ju HY et al. Cancer Res Treat, May 2025 (epub ahead of print) – open access publication
• Management of children and adolescents with chronic myeloid leukemia in chronic-phase: International pediatric chronic myeloid leukemia expert panel recommendations
  Millot F et al. Leukemia, March 2025 (epub ahead of print)

Search here for more publications on pediatric CML